Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
MetaMinds Group Partners with NFTrends
-
Toyota Releases Sales, Production, and Export Results for February 2024
-
Trip.com's Global 3.3 Promotion Sees Record Success in Asia and Europe
-
CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation
-
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
-
EverEx Secures iF Design Award for “MORA,” a Leading Musculoskeletal Rehabilitation Solution
-
Taiwan’s Taitung County Holds Tourism Promotion Event in South Korea
-
CheckPros Launches Prestigious Scholarship for Aspiring Entrepreneurs
-
Liberty Empowers Australians to Enhance Digital Skills
-
HOME AFFORDABILITY IMPROVES SLIGHTLY ACROSS U.S. DURING FIRST QUARTER BUT REMAINS DIFFICULT FOR AVERAGE WORKERS
-
ATTENTION SEEKERS SELECTS ELUVIO FOR NEXT-GEN KEYSTREAM: SERVICE TO ENABLE BRANDS TO SECURELY STREAM EMBARGOED PRODUCT LAUNCHES AND PRIVATE EVENTS TO PRESS AND GLOBAL INFLUENCERS
-
Amish Patel Joins Sierra Space as Chief Operating Officer
-
Airties Launches Orbit: Continuous Test Automation Platform for Managed Wi-Fi Deployments
-
JND eDiscovery Receives National Law Journal Hall of Fame Award in Two Categories
-
Greenberg Capital Launches New Panthers University
-
Ecopetrol publishes financial information for the year 2023
-
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
-
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
-
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
-
Take-Two Interactive Software, Inc. to Acquire The Gearbox Entertainment Company Inc., Developer of Highly Successful Borderlands Franchise
-
From Ningbo to the world: China's port city evolving into global opening-up hub
-
TD SYNNEX Announces Pricing of Upsized Secondary Public Offering of Common Stock and Concurrent Share Repurchase
-
Rubicon Organics Reports 2023 Financial Results
-
Ciscom's ICT Acquisition of Prospect Media Group Contributes to 'Stellar' Year-End Earnings for 2023
-
Noah Holdings Posts Solid Q4 and Full-Year Financial Performance
-
China Medical System (867.HK)2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs
-
An Incredible Show of Partnership for Port Houston
-
Seabridge Gold Files 2023 Annual Information Form, Year End Audited Financial Statements and MD&A
-
FICO Survey: Indonesian Focus on Identity Theft Persists Amidst Escalating Real-Time Payment Risks
-
Toshiba Launches SmartMCD™ Series Gate Driver ICs with Embedded Microcontroller
-
Cannabix Technologies Announces Resignation of Kulwant Malhi
-
Alset Capital Inc. Announces Frankfurt Stock Exchange Listing and Engagement of Corporate Awareness Providers, Including Omni8 Communications Inc.
-
UPDATE -- Toronto & York Region Labour Council: No More Cuts – Fund Our Schools NOW!
-
Jereh Group Unveils Revolutionary GreenWell Hazardous Waste Treatment Equipment at Beijing cippe
-
Flash News: OKX Ventures Announces Strategic Investment in MyShell, Pioneering AI-Integrated Web3 Technologies
-
Sony Electronics Delivers Firmware Updates including C2PA Compliancy as a Next Step to Ensure Authenticity of Images
-
IberAmerican Lithium Announces Annual 2023 Financial Results
-
XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024
-
BLUEBIRD ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Bluebird Stockholders and Encourages Investors to Contact the Firm


